Home >> Signaling Pathways >> Immunology/Inflammation

Immunology/Inflammation

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

Targets for  Immunology/Inflammation

Products for  Immunology/Inflammation

  1. Cat.No. Product Name Information
  2. GC48458 Betulinic glycine amide A derivative of betulinic acid Betulinic glycine amide  Chemical Structure
  3. GC48520 Betulonaldehyde A pentacyclic triterpenoid Betulonaldehyde  Chemical Structure
  4. GC46100 BHBM An acylhydrazone with antifungal activity BHBM  Chemical Structure
  5. GC18200 BI-605906 BI-605906 is an inhibitor of inhibitor of kappa B kinase subunit β (IKKβ; IC50 = 380 nM). BI-605906  Chemical Structure
  6. GC60076 Bigelovin Bigelovin, a sesquiterpene lactone isolated from Inula helianthus-aquatica, is a selective retinoid X receptor α agonist. Bigelovin suppresses tumor growth through inducing apoptosis and autophagy via the inhibition of mTOR pathway regulated by ROS generation. Bigelovin  Chemical Structure
  7. GC49708 Biliverdin (technical grade) A bile pigment Biliverdin (technical grade)  Chemical Structure
  8. GC49513 Bim/BOD (IN) Polyclonal Antibody For immunodetection of Bim-related proteins Bim/BOD (IN) Polyclonal Antibody  Chemical Structure
  9. GC52355 BimS BH3 (51-76) (human) (trifluoroacetate salt) A Bim-derived peptide BimS BH3 (51-76) (human) (trifluoroacetate salt)  Chemical Structure
  10. GC49724 BIO-1211 (trifluoroacetate salt) A peptide inhibitor of α4β1 integrin BIO-1211 (trifluoroacetate salt)  Chemical Structure
  11. GC49200 Biotin (R)-Sulfoxide A metabolite of biotin Biotin (R)-Sulfoxide  Chemical Structure
  12. GC49170 Biotin (S)-sulfoxide An inactive metabolite of biotin Biotin (S)-sulfoxide  Chemical Structure
  13. GC52326 Biotin-PEG4-LL-37 (human) (trifluoroacetate salt) A biotinylated and pegylated form of LL-37 Biotin-PEG4-LL-37 (human) (trifluoroacetate salt)  Chemical Structure
  14. GC42941 Bis(methylthio)gliotoxin Bis(methylthio)gliotoxin is a fungal metabolite originally isolated from G. Bis(methylthio)gliotoxin  Chemical Structure
  15. GC42943 Bischloroanthrabenzoxocinone Bacterial type II fatty acid synthesis (FAS-II) is mediated by a series of enzymes, each of which may be targeted by potential antibiotics. Bischloroanthrabenzoxocinone  Chemical Structure
  16. GC68308 Bisdemethoxycurcumin-d8 Bisdemethoxycurcumin-d8  Chemical Structure
  17. GC18716 Bisindolylmaleimide XI (hydrochloride) Bisindolylmaleimide XI (BIM XI) is a selective, cell-permeable protein kinase C (PKC) inhibitor that displays 10-fold greater selectivity for PKCα (IC50 = 9 nM) and 4-fold greater selectivity for PKCβI (IC50 = 28 nM) over Ca2+-independent PKCε (IC50 = 108 nM). Bisindolylmaleimide XI (hydrochloride)  Chemical Structure
  18. GC17707 Bismuth Subsalicylate Prostaglandin G/H Synthase 1/2 inhibitor Bismuth Subsalicylate  Chemical Structure
  19. GC49041 Bisucaberin A siderophore with anticancer activity Bisucaberin  Chemical Structure
  20. GC66485 Bis[3,4,6-trichloro-2-(pentyloxycarbonyl)phenyl] oxalate Bis[3,4,6-trichloro-2-(pentyloxycarbonyl)phenyl] oxalate is a fluorescent dye that can be used for generation of chemiluminescence. Bis[3,4,6-trichloro-2-(pentyloxycarbonyl)phenyl] oxalate  Chemical Structure
  21. GC35529 Bixin Bixin (BX), isolated from the seeds of Bixa orellana, is a carotenoid, possessing anti-inflammatory, anti-tumor and anti-oxidant activities. Bixin  Chemical Structure
  22. GC65428 BLM-IN-1 BLM-IN-1 (compound 29) is an effective Bloom syndrome protein (BLM) inhibitor, with a strong BLM binding KD of 1.81 μM and an IC50 of 0.95 μM for BLM. Induces DNA damage response, as well as apoptosis and proliferation arrest in cancer cells. BLM-IN-1  Chemical Structure
  23. GC45951 BLX3887 A 15-LO-1 inhibitor BLX3887  Chemical Structure
  24. GC41397 BMPO BMPO is a cyclic nitrone spin trap agent, it is a water-soluble white solid which makes BMPO purification easier than other spin trap agents. BMPO  Chemical Structure
  25. GC42953 BMS 345541 (trifluoroacetate salt) BMS 345541 is a cell permeable inhibitor of the IκB kinases IKKα and IKKβ (IC50s = 4 and 0.3 μM). BMS 345541 (trifluoroacetate salt)  Chemical Structure
  26. GC32028 BMS-066 BMS-066 is an IKKβ/Tyk2 pseudokinase inhibitor, with IC50s of 9 nM and 72 nM, respectively. BMS-066  Chemical Structure
  27. GC13926 BMS-345541(free base) BMS-345541(free base) is a selective inhibitor of the catalytic subunits of IKK (IKK-2 IC50=0.3 μM, IKK-1 IC50=4 μM). BMS-345541(free base) binds at an allosteric site of IKK. BMS-345541(free base)  Chemical Structure
  28. GC42957 BMS-8 BMS-8 is a small molecule inhibitor of the interaction between programmed death protein 1 (PD-1) and its ligand programmed cell death ligand 1 (PD-L1) with an IC50 value of 146 nM in a homogeneous time-resolved fluorescence (HTRF) binding assay. BMS-8  Chemical Structure
  29. GC62507 BMS-986299 BMS-986299 (compound 112) is a first-in-class NLRP3 inflammasome agonist with an EC50 of 1.28 μM. BMS-986299  Chemical Structure
  30. GC48495 BMS-P5 BMS-P5 is a specific and orally active peptidylarginine deiminase 4 (PAD4) inhibitor. BMS-P5 blocks MM-induced NET formation and delays progression of MM in a syngeneic mouse model. BMS-P5  Chemical Structure
  31. GC12399 BMS345541 hydrochloride A selective inhibitor of IKKα and IKKβ BMS345541 hydrochloride  Chemical Structure
  32. GA20967 Boc-D-His-OH An amino acid building block Boc-D-His-OH  Chemical Structure
  33. GA20972 Boc-D-Leu-OSu An amino acid-containing building block Boc-D-Leu-OSu  Chemical Structure
  34. GC46937 Boc-Glu-OBzl An amino acid-containing building block Boc-Glu-OBzl  Chemical Structure
  35. GC46938 Boc-L-Arg-OH An amino acid building block Boc-L-Arg-OH  Chemical Structure
  36. GC49717 Boc-LGR-pNA (acetate) A chromogenic substrate for endotoxins Boc-LGR-pNA (acetate)  Chemical Structure
  37. GC42967 Boromycin Boromycin is a boron-containing macrolide antibiotic that has been found in Streptomyces. Boromycin  Chemical Structure
  38. GC65010 Bortezomib-d8 Bortezomib-d8 (PS-341-d8) is the deuterium labeled Bortezomib. Bortezomib (PS-341) is a reversible and selective proteasome inhibitor, and potently inhibits 20S proteasome (Ki=0.6 nM) by targeting a threonine residue. Bortezomib disrupts the cell cycle, induces apoptosis, and inhibits NF-κB. Bortezomib is the first proteasome inhibitor anticancer agent. Anti-cancer activity. Bortezomib-d8  Chemical Structure
  39. GC40009 Bostrycin Bostrycin is an anthraquinone originally isolated from B. Bostrycin  Chemical Structure
  40. GC48365 Bottromycin A2 An antibiotic Bottromycin A2  Chemical Structure
  41. GC46946 BPC 157 (acetate) A pentadecapeptide with diverse biological activities BPC 157 (acetate)  Chemical Structure
  42. GC52240 BPH-1358 An inhibitor of UPPS and FPPS BPH-1358  Chemical Structure
  43. GC13506 Bradykinin (acetate)

    inflammatory mediator

    Bradykinin (acetate)  Chemical Structure
  44. GC52145 Bradykinin (human, mouse, rat, bovine) (acetate) Bradykinin (human, mouse, rat, bovine) (acetate)  Chemical Structure
  45. GC52424 Bradykinin Fragment (1-5) (trifluoroacetate salt) A metabolite of bradykinin Bradykinin Fragment (1-5) (trifluoroacetate salt)  Chemical Structure
  46. GC52101 Brazilein Brazilein is an important immunosuppressive component isolated from Caesalpinia sappan L. Brazilein  Chemical Structure
  47. GC40824 Brevicompanine B Brevicompanine B is a fungal metabolite originally isolated from P. Brevicompanine B  Chemical Structure
  48. GC35553 Brevifolincarboxylic acid Brevifolincarboxylic acid is extracted from Polygonum capitatum, has inhibitory effect on the aryl hydrocarbon receptor (AhR). Brevifolincarboxylic acid  Chemical Structure
  49. GC68807 Briakinumab

    Briakinumab (ABT-874) is a fully human monoclonal antibody that targets and neutralizes IL-12/23p40. Briakinumab specifically targets and neutralizes both IL-12 and IL-23. It is being studied for its potential use in rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis.

    Briakinumab  Chemical Structure
  50. GC67748 Brodalumab Brodalumab  Chemical Structure
  51. GC42978 Bromamphenicol Bromamphenicol is a dibrominated derivative of the antibiotic chloramphenicol. Bromamphenicol  Chemical Structure
  52. GC16921 Bromhexine HCl Bromhexine HCl is a potent and specific TMPRSS2 protease inhibitor with an IC50 of 0.75 μM. Bromhexine HCl  Chemical Structure
  53. GC46024 Bromodiphenhydramine (hydrochloride) A histamine H1 receptor antagonist Bromodiphenhydramine (hydrochloride)  Chemical Structure
  54. GC16345 Bropirimine Bropirimine is a synthetic agonist for toll-like receptor 7 (TLR7). Bropirimine inhibits differentiation of osteoclast precursor cells into osteoclasts via TLR7-mediated production of IFN-β. Bropirimine is an orally active immunomodulator that has demonstrated anticancer activity in transitional cell carcinoma in situ (CIS) in both the bladder and upper urinary tract. Bropirimine  Chemical Structure
  55. GC34070 Brusatol (NSC 172924) Brusatol (NSC 172924) (NSC172924) is a unique inhibitor of the Nrf2 pathway that sensitizes a broad spectrum of cancer cells to Cisplatin and other chemotherapeutic agents. Brusatol (NSC 172924) enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism. Brusatol (NSC 172924) can be developed into an adjuvant chemotherapeutic agent. Brusatol (NSC 172924) increases cellular apoptosis. Brusatol (NSC 172924)  Chemical Structure
  56. GC62878 Bryonolic acid Bryonolic acid is an active triterpenoid compound with immunomodulatory, anti-inflammatory, antioxidant and anticancer activities. Bryonolic acid  Chemical Structure
  57. GC46956 Budesonide-d8 An internal standard for the quantification of budesonide Budesonide-d8  Chemical Structure
  58. GC33134 Bufotalin Bufotalin is a steroid lactone isolated from Venenum Bufonis with potently antitumor activities. Bufotalin induces cancer cell apoptosis and also induces endoplasmic reticulum (ER) stress activation. Bufotalin  Chemical Structure
  59. GC46960 Buprofezin An insecticide Buprofezin  Chemical Structure
  60. GC48376 Burnettramic Acid A A fungal metabolite with diverse biological activities Burnettramic Acid A  Chemical Structure
  61. GC49136 Butenafine-13C-d3 (hydrochloride) An internal standard for the quantification of butenafine Butenafine-13C-d3 (hydrochloride)  Chemical Structure
  62. GC30067 Butylhydroxyanisole (Butylated hydroxyanisole) Butylhydroxyanisole (Butylated hydroxyanisole) (Butylated hydroxyanisole) is an antioxidant used as a food additive preservative. Butylhydroxyanisole (Butylated hydroxyanisole)  Chemical Structure
  63. GC46104 Butyric Acid-d7 An internal standard for the quantification of sodium butyrate Butyric Acid-d7  Chemical Structure
  64. GC46106 Butyrolactone V A fungal metabolite Butyrolactone V  Chemical Structure
  65. GC14601 BW 755C dual inhibitor of 5-lipoxygenase (5-LO) and cyclooxygenase (COX) pathways BW 755C  Chemical Structure
  66. GC10709 BW-B 70C

    5-Lipoxygenase inhibitor,potent and selective

    BW-B 70C  Chemical Structure
  67. GC19432 BXL-628 BXL-628 (BXL-628) is a selective, orally active vitamin D receptor (VDR) agonist. BXL-628  Chemical Structure
  68. GC12325 BYK 191023 dihydrochloride INOS inhibitor,potent and selective BYK 191023 dihydrochloride  Chemical Structure
  69. GA21221 Bz-Nle-Lys-Arg-Arg-AMC Bz-Nle-Lys-Arg-Arg-AMC is a fluorogenic tetra-peptide substrate for yellow fever virus (YFV) non-structural 3 (NS3). Bz-Nle-Lys-Arg-Arg-AMC  Chemical Structure
  70. GC46983 C-170 C-170 (C-170) is a potent and covalent STING inhibitor. C-170  Chemical Structure
  71. GC46984 C-171 C-171 is an inhibitor of stimulator of interferon genes (STING). C-171  Chemical Structure
  72. GC33823 C-176 (STING inhibitor 1) C-176 (STING inhibitor 1) is a strong and covalent mouse STING inhibitor. C-176 (STING inhibitor 1)  Chemical Structure
  73. GC38494 C-178 A STING inhibitor C-178  Chemical Structure
  74. GC13643 c-di-AMP

    C-di-AMP is a STING agonist, which binds to the transmembrane protein STING, thereby activating the TBK3-IRF3 signaling pathway, subsequently triggering the production of type I IFN and TNF.

    c-di-AMP  Chemical Structure
  75. GC62893 c-di-AMP diammonium c-di-AMP diammonium is a STING agonist, which binds to the transmembrane protein STING thereby activating the TBK3-IRF3 signaling pathway, subsequently triggering the production of type I IFN and TNF. c-di-AMP diammonium  Chemical Structure
  76. GC64445 c-di-AMP disodium c-di-AMP (Cyclic diadenylate) sodium is a STING agonist, which binds to the transmembrane protein STING thereby activating the TBK3-IRF3 signaling pathway, subsequently triggering the production of type I IFN and TNF. c-di-AMP disodium  Chemical Structure
  77. GC62198 c-di-AMP sodium

    C-di-AMP is a STING agonist, which binds to the transmembrane protein STING, thereby activating the TBK3-IRF3 signaling pathway, subsequently triggering the production of type I IFN and TNF.

    c-di-AMP sodium  Chemical Structure
  78. GC50687 c-Di-AMP sodium salt c-Di-AMP sodium salt  Chemical Structure
  79. GC50292 c-Di-GMP sodium salt Endogenous STING and DDX41 agonist; activates STING-dependent signaling c-Di-GMP sodium salt  Chemical Structure
  80. GC43007 C12 Galactosylceramide (d18:1/12:0) C12 Galactosylceramide is a bioactive sphingolipid. C12 Galactosylceramide (d18:1/12:0)  Chemical Structure
  81. GC43031 C16 Galactosylceramide (d18:1/16:0) C16 Galactosylceramide is a glycosphingolipid that contains a galactose moiety attached to a ceramide acylated with palmitic acid . C16 Galactosylceramide (d18:1/16:0)  Chemical Structure
  82. GC43032 C16 Globotriaosylceramide (d18:1/16:0) C16 globotriaosylceramide is an endogenous sphingolipid found in mammalian cell membranes that is synthesized from C16 lactosylceramide. C16 Globotriaosylceramide (d18:1/16:0)  Chemical Structure
  83. GC43049 C18 Globotriaosylceramide (d18:1/18:0) C18 globotriaosylceramide is an endogenous sphingolipid found in mammalian cell membranes that is synthesized from lactosylceramide. C18 Globotriaosylceramide (d18:1/18:0)  Chemical Structure
  84. GC43052 C18 Phytoceramide (t18:0/18:0) C18 Phytoceramide (t18:0/18:0) (Cer(t18:0/18:0)) is a bioactive sphingolipid found in S. C18 Phytoceramide (t18:0/18:0)  Chemical Structure
  85. GC40141 C18 Phytoceramide-d3 (t18:0/18:0-d3) C18 Phytoceramide-d3 (t18:0/18:0-d3) is intended for use as an internal standard for the quantification of C18 phytoceramide (t18:0/18:0) by GC- or LC-MS. C18 Phytoceramide-d3 (t18:0/18:0-d3)  Chemical Structure
  86. GC43060 C2 Adamantanyl Globotriaosylceramide (d18:1/2:0) C2 Adamantanyl globotriaosylceramide (AdaGb3) is a bioactive sphingolipid and water-soluble form of globotriaosylceramide that contains an adamantanyl group in place of the fatty acyl chain. C2 Adamantanyl Globotriaosylceramide (d18:1/2:0)  Chemical Structure
  87. GC40709 C2 L-threo Ceramide (d18:1/2:0) C2 L-threo Ceramide is a bioactive sphingolipid and cell-permeable analog of naturally occurring ceramides. C2 L-threo Ceramide (d18:1/2:0)  Chemical Structure
  88. GC43071 C22 Sphingomyelin (d18:1/22:0) C22 Sphingomyelin is a naturally occurring form of sphingomyelin. C22 Sphingomyelin (d18:1/22:0)  Chemical Structure
  89. GC45834 C24 (2'(R)-hydroxy) Phytoceramide (t18:0/24:0) A bioactive sphingolipid C24 (2'(R)-hydroxy) Phytoceramide (t18:0/24:0)  Chemical Structure
  90. GC43076 C24 Phytosphingosine (t18:0/24:0) C24 Phytosphingosine (t18:0/24:0) is a phytoceramide, which is a family of sphingolipids found in the intestine, kidney, and extracellular spaces of the stratum corneum of the mammalian epidermis. C24 Phytosphingosine (t18:0/24:0)  Chemical Structure
  91. GC43077 C24:1 3'-sulfo Galactosylceramide (d18:1/24:1(15Z)) C24:1 3'-sulfo Galactosylceramide is a member of the sulfatide class of glycolipids. C24:1 3'-sulfo Galactosylceramide (d18:1/24:1(15Z))  Chemical Structure
  92. GC47007 C26 Sphingomyelin (d18:1/26:0) A sphingolipid C26 Sphingomyelin (d18:1/26:0)  Chemical Structure
  93. GC33820 C29 C29 is a Toll-like receptor 2 (TLR2) inhibitor. C29  Chemical Structure
  94. GC35575 C3a (70-77) TFA C3a (70-77) TFA  Chemical Structure
  95. GC31928 C3a 70-77 (Complement 3a (70-77)) C3a 70-77 (Complement 3a (70-77)) is an octapeptide corresponding to the COOH terminus of C3a, exhibits the specificity and 1 to 2% biologic activities of C3a. C3a 70-77 (Complement 3a (70-77))  Chemical Structure
  96. GC43084 C4 Ceramide (d18:1/4:0)

    C4 Ceramide is a bioactive sphingolipid and cell-permeable analog of naturally occurring ceramides.

    C4 Ceramide (d18:1/4:0)  Chemical Structure
  97. GC40688 C6 D-threo Ceramide (d18:1/6:0) C6 D-threo Ceramide is a bioactive sphingolipid and cell-permeable analog of naturally occurring ceramides., C6 D-threo Ceramide is cytotoxic to U937 cells in vitro (IC50 = 18 μM). C6 D-threo Ceramide (d18:1/6:0)  Chemical Structure
  98. GC40690 C6 L-threo Ceramide (d18:1/6:0) C6 L-threo Ceramide (d18:1/6:0) is a bioactive sphingolipid and cell-permeable analog of naturally occurring ceramides. C6 L-threo Ceramide (d18:1/6:0)  Chemical Structure
  99. GC43110 C8 Galactosylceramide (d18:1/8:0) C8 Galactosylceramide is a synthetic C8 short-chain derivative of known membrane microdomain-forming sphingolipids. C8 Galactosylceramide (d18:1/8:0)  Chemical Structure
  100. GC43113 Caerulein (acetate) Caerulein is an oligopeptide originally isolated from skin extracts of H. Caerulein (acetate)  Chemical Structure
  101. GC40352 Cafestol Cafestol is a natural diterpene which is abundant in unfiltered coffee. Cafestol  Chemical Structure

Items 701 to 800 of 2909 total

per page
  1. 6
  2. 7
  3. 8
  4. 9
  5. 10

Set Descending Direction